AML with TP53 mutations are present in ~6% of patients with AML and can be combined into a genomic category with chromosomal aneuploidy (13% of AML) as the two types of genetic alterations are closely correlated (12). The gene discussed is TP53; the disease is acute myeloid leukemia.